NCT00111436 Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects Status COMPLETED Phase PHASE3
NCT00111423 Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT00111410 Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE4
NCT00111137 Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy Status COMPLETED Phase PHASE3
NCT00111111 An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis Status COMPLETED Phase PHASE3
NCT00111098 Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis Status COMPLETED Phase PHASE3
NCT00111007 A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE3
NCT00110994 Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE2
NCT00110981 Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis Status COMPLETED Phase PHASE4
NCT00110955 Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy Status COMPLETED Phase PHASE3
NCT00110929 Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD) Status COMPLETED Phase PHASE2
NCT00110916 Treatment for Patients With Osteoarthritis (OA) of the Knee Status COMPLETED Phase PHASE2
NCT00110903 Treatment for Subjects With Active Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE3
NCT00110890 A Research Study for Patients With End-Stage Renal Disease (ESRD) Status COMPLETED Phase PHASE4
NCT00110656 Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation Status COMPLETED Phase N/A
NCT00109031 Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) Status COMPLETED Phase PHASE3
NCT00104650 Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates Status COMPLETED Phase PHASE2
NCT00102921 Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE2